You are viewing archived content
Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.
Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2010 or most recent year available
Part (iii) All outpatient clients, age distribution by primary drug (%)
| Substance | <15 | 15–19 | 20–24 | 25–29 | 30–34 | 35–39 | 40–44 | 45+ | Mean age | Age known (base) | Age not known |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opioids | 0.0 | 2.1 | 11.5 | 20.5 | 21.6 | 18.3 | 13.8 | 12.1 | 34.1 | 175983 | 1910 |
| Cocaine | 0.1 | 3.8 | 14.6 | 22.1 | 21.7 | 17.1 | 11.2 | 9.4 | 32.7 | 57015 | 3662 |
| Stimulants | 0.6 | 12.3 | 24.7 | 22.7 | 16.6 | 10.4 | 6.6 | 6.1 | 29.0 | 15907 | 75 |
| Hypnotics and sedatives | 0.6 | 5.8 | 11.1 | 12.8 | 13.9 | 12.9 | 13.1 | 29.8 | 36.2 | 7340 | 157 |
| Hallucinogens | 1.4 | 19.1 | 30.8 | 21.7 | 11.1 | 7.3 | 4.3 | 4.2 | 26.6 | 1296 | 1 |
| Volatile substances | 25.4 | 35.4 | 10.0 | 10.1 | 7.4 | 4.4 | 4.5 | 2.7 | 21.9 | 779 | 6 |
| Cannabis | 3.5 | 30.7 | 25.7 | 16.8 | 9.9 | 6.1 | 3.9 | 3.4 | 25.0 | 97692 | 1326 |
| Other substances | 1.5 | 10.1 | 16.6 | 15.7 | 13.5 | 12.0 | 10.4 | 20.2 | 32.9 | 5494 | 5 |
| Total | 1.1 | 10.9 | 16.5 | 19.6 | 17.9 | 14.2 | 10.3 | 9.5 | 31.2 | 361506 | 7142 |
Notes
All countries included excluding Lithuania.
The number of treatment clients in each country is listed in Table TDI-7.
See also Table TDI-103 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.
Source:
Reitox national reports 2011 — Table TDI outpatient and inpatient treatment centres.